Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AGN - ALLERGAN MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation into Whether the Sale of Allergan PLC is Fair to Shareholders; Investors are Encouraged to Contact the Firm - AGN


AGN - ALLERGAN MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation into Whether the Sale of Allergan PLC is Fair to Shareholders; Investors are Encouraged to Contact the Firm - AGN

NEW YORK, NY / ACCESSWIRE / September 26, 2019 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Allergan plc (NYSE:AGN) to AbbVie Inc. ("AbbVie") is fair to Allergan shareholders. On behalf of Allergan shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

If you are an Allergan shareholder and would like to discuss your legal rights and options, please visit Allergan Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The shareholder votes on the proposed transaction is scheduled for October 14, 2019. Under the terms of the agreement, Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share that they hold. On June 19, 2019, JP Morgan set a target price for Allergan at $200.00 per share.

The Allergan merger investigation concerns whether Allergan and its Board of Directors violated the federal securities laws and/or their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Allergan shareholders; (2) determine whether AbbVie is underpaying for Allergan; and (3) disclose all material information necessary for Allergan shareholders to adequately assess and value the merger consideration.

If you are an Allergan shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/allergan-plc-agn-stock-merger-abbvie/ or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/561141/ALLERGAN-MERGER-INVESTIGATION-Halper-Sadeh-LLP-Announces-Investigation-into-Whether-the-Sale-of-Allergan-PLC-is-Fair-to-Shareholders-Investors-are-Encouraged-to-Contact-the-Firm--AGN

Stock Information

Company Name: Allergan plc
Stock Symbol: AGN
Market: NYSE
Website: allergan.com

Menu

AGN AGN Quote AGN Short AGN News AGN Articles AGN Message Board
Get AGN Alerts

News, Short Squeeze, Breakout and More Instantly...